Search results for "hpv"

showing 10 items of 166 documents

Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review.

2011

Human papillomavirus (HPV) in oral carcinoma (OSCC) and potentially malignant disorders (OPMD) is controversial. The primary aim was to calculate pooled risk estimates for the association of HPV with OSCC and OPMD when compared with healthy oral mucosa as controls. We also examined the effects of sampling techniques on HPV detection rates. Methods: Systematic review was performed using PubMed (January 1966-September 2010) and EMBASE (January 1990-September 2010). Eligible studies included randomized controlled, cohort and cross-sectional studies. Pooled data were analysed by calculating odds ratios, using a random effects model. Risk of bias was based on characteristics of study group, appr…

HPVprecancerAlphapapillomavirusmeta-analysiCohort StudiespremalignancyBiasSettore MED/28 - Malattie OdontostomatologicheRisk Factorscase–controlHumansbiopsyhumanProspective StudiesRandomized Controlled Trials as Topiclichen planuerythroplakiaadultPapillomavirus Infectionsoral cancerCell Transformation ViralControl GroupsCross-Sectional StudiesleukoplakiacytologyMouth NeoplasmsPrecancerous ConditionsOral diseases
researchProduct

Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with H…

2011

Abstract Background There is increasing evidence for the role of High Risk (HR) Human PapillomaVirus (HPV) in the pathogenesis of Oral Squamous Cell Carcinoma (OSCC). The E6 and E7 oncogenes from HR HPVs are responsible for the deregulation of p53 and pRB proteins involved in cell cycle and apoptotic pathways. In cell lines experiments, the HPV E7 protein seems to be able to enhance Hypoxia Inducible Factor-1 alpha (HIF-1α) activity, normally involved in the response to hypoxia and able to enhance angiogenesis. Results We studied tumor specimens from 62 OSCC; a higher prevalence of tumors in TNM stage II and also in pT2 class between OSCC infected positive HPV16 DNA than non-infected ones w…

HPV16Cancer ResearchPathologymedicine.medical_specialtyHPVNecrosisAngiogenesisEpidemiologyAlpha (ethology)BiologyOral Squamous Cell Carcinomalcsh:RC254-282lcsh:Infectious and parasitic diseasesPathogenesisHypoxia-Inducible Factor 1-Alphachemistry.chemical_compoundmedicinelcsh:RC109-216E7Oral Squamous Cell Carcinoma Hif-1α HPV HPV16 E7virus diseasesHypoxia (medical)lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensfemale genital diseases and pregnancy complicationsstomatognathic diseasesInfectious DiseaseschemistryOncologyApoptosisCancer researchmedicine.symptomHif-1αDNAResearch ArticleInfectious agents and cancer
researchProduct

Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation

2018

In Italy, the Human Papillomavirus (HPV) vaccination was implemented for twelve years old girls in 2007, but its coverage was lower than the recommended level. Sicily is one of the Italian administrative regions with lower vaccination coverage, with a value of 59% for those born in 1996 increasing to 62% coverage for those born in 1999. The aim of the study was to investigate factors associated with the refusal of HPV vaccination among young adult women of Palermo, Italy. The study was approved by the Ethics Committee of the Policlinico “Paolo Giaccone” Hospital (Palermo 1) and the questionnaire was validated in a convenience sample representing 10% of the young women. A cross-s…

Health Knowledge Attitudes PracticeVaccination scheduleHealth Toxicology and Mutagenesislcsh:MedicineSettore MED/42 - Igiene Generale E Applicata0302 clinical medicineVaccination RefusalSurveys and QuestionnairesHealth belief model030212 general & internal medicineYoung adulthuman papillomavirusResponse rate (survey)education.field_of_study030219 obstetrics & reproductive medicineVaccinationHPV infectionVaccinationItalyFemalewomencatch upAdultmedicine.medical_specialtyAdolescenthuman papillomavirus; vaccine refusal; hesitancy; women; school based; Health Belief Model; gynaecologist; general practitioner; survey; catch upPopulationArticleYoung Adult03 medical and health sciencesschool basedmedicineHumanssurveyPapillomavirus Vaccineseducationbusiness.industryPublic healthPapillomavirus Infectionslcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasegynaecologistCross-Sectional StudiesHuman papillomaviruFamily medicinegeneral practitionervaccine refusalhesitancybusinessCatch up; General practitioner; Gynaecologist; Health Belief Model; Hesitancy; Human papillomavirus; School based; Survey; Vaccine refusal; Women; Public Health Environmental and Occupational Health; Health Toxicology and MutagenesisHealth Belief ModelInternational Journal of Environmental Research and Public Health; Volume 15; Issue 4; Pages: 770
researchProduct

Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation

2014

Understanding perceptions and characteristics of human papillomavirus (HPV) vaccinated and non-vaccinated girls can inform communication activities and vaccine delivery strategies. The purpose of this study was to evaluate knowledge and factors associated with HPV unvaccinated girls after five years of vaccination program implementation in Sicily, an Italian region with low vaccination coverage (<50.0%). A cross-sectional study was conducted through a questionnaire designed to assess knowledge and vaccination status of girls of 1997, 1998, 1999, and 2000 birth cohorts. The sample consisted of 350 girls who attended three high schools. Multivariable logistic regression analysis was conducted…

Health Knowledge Attitudes Practicemedicine.medical_specialtyAdolescentCross-sectional studyImmunologyLogistic regressionSurveys and QuestionnairesmedicineHumansImmunology and AllergyPapillomavirus VaccinesHPV vaccination barriers HPV vaccination knowledge HPV infection knowledge friends as source of information pediatrician/general practitioner as source of information HPV vaccine efficacy HPV vaccine securityStudentsSicilyPharmacologyGynecologyCervical cancerbusiness.industryPapillomavirus InfectionsVaccinationPatient Acceptance of Health Caremedicine.diseaseVaccinationCross-Sectional StudiesIncreased riskVaccination coverageFamily medicineVaccine refusalFemaleBirth cohortbusinessResearch PaperHuman Vaccines &amp; Immunotherapeutics
researchProduct

Drivers for human papillomavirus vaccination in Valencia (Spain)

2018

Objective: To describe the drivers associated with HPV vaccination in adolescent girls and their parent's opinion on the vaccine. Methods: We conducted an observational and cross-sectional study on adolescent girls and their parents in Valencia (Spain), between September 2011 and June 2012. A consultation was made at a random sample of schools of the 14-year-old girls that should have received the vaccine in the free vaccination programme. We ran a personal survey on knowledge and attitudes regarding HPV infection and the vaccine. A binary logistic regression model was performed to determine which factors were most associated with vaccination. Results: The survey was run on a binomial of 1,…

Health Knowledge Attitudes Practicemedicine.medical_specialtyHuman papillomavirusAdolescentDriversCross-sectional studyCulturePsychology AdolescentMothersLogistic regressionSampling Studies03 medical and health sciences0302 clinical medicineVaccination RefusalInfermeriamedicineHumansPapillomavirus Vaccines030212 general & internal medicineVacunacióMotivationVaccines030505 public healthImmunization Programsbusiness.industryNurselcsh:Public aspects of medicinePapillomavirus InfectionsVaccinationPublic Health Environmental and Occupational HealthHPV infectionlcsh:RA1-1270Patient Acceptance of Health Caremedicine.diseaseCountry of originConfidence intervalSurgeryVaccination RefusalVaccinationCross-Sectional StudiesSpainFamily medicineAttitudesFemaleObservational study0305 other medical sciencebusiness
researchProduct

HPV group- and type-specific concordance in HPV infected sexual couples.

2007

The concordance of human papillomavirus (HPV) groups and types was evaluated in 45 sexual couples with both partners HPV infected, by analyzing cervical samples from women and three genital sites (penile brushing, urethral brushing, and semen) from men. When grouping HPV types, no significant HPV group sharing was found between partners, either considering samples from any male site (concordance: 55.5%; P = 0.11) or from each site (concordance by penile brushing, 37.8%; urethral brushing, 24.5%; semen, 22.3%; P > 0.05). Examining individual HPV types, using samples from any male site, concordance was found in 29 (64.4%; P = 0.036) couples; significant concordance was evident for 16 HPV geno…

Hpv genotypesAdultMalemedicine.medical_specialtyPenile DiseasesConcordanceSemenhuman papillomavirus (HPV) concordance sexual partnersAlphapapillomavirusUterine Cervical DiseasesVirologymedicineHumansSex organHuman papillomavirusGynecologyHpv typesbusiness.industryPapillomavirus InfectionsType specificMiddle AgedInfectious DiseasesSexual PartnersDNA ViralFemalebusinessJournal of medical virology
researchProduct

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations

2021

AbstractHuman papilloma virus infection (HPV) is the most common sexually transmitted disease. Little is known about male infection. Nonavalent vaccine against types 6/11/16/18/31/33/45/52/58 was approved and neutral gender immunization programs have been proposed. This study evaluates the potential impact of nonavalent vaccine compared to quadrivalent in male living in Sicily (Italy). 58.7% of samples were HPV positive and forty-four types of HPV were identified. A significant higher estimated coverage of nonavalent vaccine than quadrivalent was observed (64.3% vs. 45.8%), with absolute and relative additional impact of 20.1% and 47.2%, respectively. Low impact of the vaccine were calculat…

Hpv genotypesSexually transmitted diseaseAdultMalemedicine.medical_specialtyScienceDiseasesMicrobiologyArticle03 medical and health sciencesYoung Adult0302 clinical medicineMedical researchHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Internal medicineMedicineHumansHuman papilloma virus infection030212 general & internal medicinePapillomavirus VaccinesPapillomaviridaeSicilyAgedPotential impactMultidisciplinarybusiness.industryHPV PositivePapillomavirus InfectionsQHealth careRMiddle Aged030220 oncology & carcinogenesisCase-Control StudiesMedicinebusinessSexual contactHPV nonavalent vaccine men infectious desease
researchProduct

HPV-DNA Positive/p16 IHC Negative Oral Squamous Cell Carcinoma: A Case Report

2019

Hpv testingHPVbusiness.industryCancer researchImmunohistochemistryMedicineBasal cellp16business
researchProduct

Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.

2003

Abstract Persistent infection with human papillomavirus (HPV), particularly HPV16, represents the prime risk factor in cervical carcinogenesis. HPV variants ( e.g. , within the E6 gene) together with immunogenetic factors of the host may be responsible either for effective viral clearance, or alternatively, for viral persistence. Peripheral blood from 27 HPV16 positive Swedish women with cervical carcinoma, who had previously been tested for HPV16 E6 variants, was used for human leukocyte antigen (HLA) class I typing. Women with HLA-B*44, HLA-B*51, or HLA-B*57 who were infected with the HPV16 E6 variant L83V had an approximately four- to fivefold increased risk for cancer compared with cont…

ImmunologyUterine Cervical NeoplasmsHuman leukocyte antigenBiologyEpitopeHLA AntigensRisk FactorsmedicineImmunology and AllergyHumansGenetic Predisposition to DiseaseTypingAlleleGenePapillomaviridaeCervical cancerSwedenPapillomavirus InfectionsHPV infectionGeneral MedicineOdds ratioOncogene Proteins Viralmedicine.diseaseVirologyRepressor ProteinsTumor Virus InfectionsImmunologyFemaleAlgorithmsHuman immunology
researchProduct

Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes.

2011

A prospective study was performed to assess the relationship between human papillomavirus (HPV) infection in 199 infertile couples and outcome of assisted reproductive technologies (ARTs). A highly statistically significant correlation between pregnancy loss rate (proportion of pregnancies detected by β-hCG that did not progress beyond 20 weeks) and positive HPV DNA testing in the male partner of infertile couples, compared with HPV negatives, was observed (66.7% vs. 15%).

InfertilityAdultMalemedicine.medical_specialtyHuman papillomavirusmedicine.medical_treatmentReproductive technologyFertilization in VitroAbortionAlphapapillomavirusPregnancymedicineHumansProspective cohort studyGynecologyPregnancyFamily CharacteristicsIn vitro fertilisationbusiness.industryObstetricsPapillomavirus InfectionsHPV infectionPregnancy Outcomevirus diseasesObstetrics and Gynecologymedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaInfectious Disease Transmission VerticalClinical trialTreatment OutcomeReproductive MedicineInfertilityFemalebusinessFertility and sterility
researchProduct